Home/Orlance/Deb Fuller
DF

Deb Fuller

CTO

Orlance

Orlance Pipeline

DrugIndicationPhase
Universal Influenza VaccineInfluenzaPre-IND
Enhanced Seasonal Influenza VaccineInfluenzaResearch
Chronic Hepatitis B VaccineHepatitis BResearch
Neoantigen Cancer Vaccine PlatformOncologyResearch